Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Sichuan Agricultural University currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are assigned to 2 distinct examiners, meaning there is no examiner overlap for the university's active matters. The portfolio is active across 2 distinct art units, which indicates that each of the 2 pending office actions is being reviewed in a different technical department.
The busiest examiner for this portfolio is STANKOVIC, BRATISLAV, who is currently overseeing 1 pending office action. Since there are 2 pending office actions in total and 2 distinct examiners, STANKOVIC, BRATISLAV and the other examiner each handle exactly 1 pending office action. This distribution shows a fragmented prosecution landscape for the university's biotechnology and pharmaceutical research.
Managing 2 pending office actions across 2 distinct art units requires the university to be prepared for two different sets of examination guidelines. Because STANKOVIC, BRATISLAV only manages 1 pending office action, the success of the portfolio is not concentrated with any single official. Instead, the 2 distinct examiners provide a diversified set of perspectives within the Biotechnology & Pharmaceuticals technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STANKOVIC, BRATISLAV | 1 | 70.0% | +21.9% |
| SPEED, DEQUANTARIUS JAVON | 1 | 70.0% | +69.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19250894 | METHOD FOR REGULATING AND CONTROLLING PLANT DISEASE AND INSECT PEST RESISTANCE BY HPS1 GENE | STANKOVIC, BRATISLAV | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18665653 | METHOD FOR USING ZMARGOS9 GENE IN DROUGHT RESISTANCE AND HIGH YIELD PRODUCTION OF MAIZE | SPEED, DEQUANTARIUS JAVON | 82d |
| 19250894 | METHOD FOR REGULATING AND CONTROLLING PLANT DISEASE AND INSECT PEST RESISTANCE BY HPS1 GENE | STANKOVIC, BRATISLAV | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19250894 | METHOD FOR REGULATING AND CONTROLLING PLANT DISEASE AND INSECT PEST RESISTANCE BY HPS1 GENE | STANKOVIC, BRATISLAV | 1662 | §102§112 | Non-Final OA | — | Pending | Jun 26, 2025 |
| 18665653 | METHOD FOR USING ZMARGOS9 GENE IN DROUGHT RESISTANCE AND HIGH YIELD PRODUCTION OF MAIZE | SPEED, DEQUANTARIUS JAVON | 1663 | §102 | Non-Final OA | 82d | Pending | May 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial